9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Adela, Inc
Degron Therapeutics Co.
Sensei Biotherapeutics, Inc.
Tempus AI
Elevation Oncology
Taproot Health
Corvus Pharmaceuticals, Inc.
Shanghai Yunying Medical Technology
Kineta Inc.
Quadriga Biosciences, Inc.
SpeciCare
Celgene
Valerio Therapeutics
Valerio Therapeutics
Astellas Pharma Inc